Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Halpern

Showing results (1-10 of 27) with videos related to

Pageof 3
Sort By:
Expert Review of Pharmacoeconomics & Outcomes Research|October 8, 2009
Pharmacoeconomic studies and the pharmaceutical industry: bias in which direction?Michael Halpern
Pharmaceuticals (Basel, Switzerland)|October 8, 2016
Cannabinoids and Dementia: A Review of Clinical and Preclinical DataSebastian Walther, Michael Halpern
Science (New York, N.Y.)|May 2, 2015
Transparency versus harassmentMichael Halpern, Michael Mann
Archives of Otolaryngology--Head & Neck Surgery|December 19, 2007
Factors predictive of survival in advanced laryngeal cancerAmy Y Chen, Michael Halpern
The Angle Orthodontist|January 7, 2010
Location and presence of permanent teeth in a complete bilateral cleft lip and palate populationRichard Michael Halpern, James Noble
Cancer Investigation|July 2, 2010
Impact of clinical and non-clinical factors on the choice of HER2 test for breast cancerMahima Ashok, Paul Griffin, Michael Halpern
Chest|January 16, 2003
Levalbuterol compared to racemic albuterol: efficacy and outcomes in patients hospitalized with COPD or asthmaTerrance Truitt, James Witko, Michael Halpern
Materials Management in Health Care|August 12, 2006
Trend shows growing orthopedic surgery case load. Will surgeons be able to keep up?Steven Kurtz, Edmund Lau, Michael Halpern, et al.
Head & Neck|April 3, 2009
Impact of treating facilities' volume on survival for early-stage laryngeal cancerAmy Y Chen, Alex Pavluck, Michael Halpern, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|December 7, 2011
Single-pill vs free-equivalent combination therapies for hypertension: a meta-analysis of health care costs and adherenceBeth Sherrill, Michael Halpern, Shahnaz Khan, et al.
Pageof 3

Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
Expert Review of Pharmacoeconomics & Outcomes Research|October 8, 2009
Pharmacoeconomic studies and the pharmaceutical industry: bias in which direction?Michael Halpern
Pharmaceuticals (Basel, Switzerland)|October 8, 2016
Cannabinoids and Dementia: A Review of Clinical and Preclinical DataSebastian Walther, Michael Halpern
Science (New York, N.Y.)|May 2, 2015
Transparency versus harassmentMichael Halpern, Michael Mann
Archives of Otolaryngology--Head & Neck Surgery|December 19, 2007
Factors predictive of survival in advanced laryngeal cancerAmy Y Chen, Michael Halpern
The Angle Orthodontist|January 7, 2010
Location and presence of permanent teeth in a complete bilateral cleft lip and palate populationRichard Michael Halpern, James Noble
Cancer Investigation|July 2, 2010
Impact of clinical and non-clinical factors on the choice of HER2 test for breast cancerMahima Ashok, Paul Griffin, Michael Halpern
Chest|January 16, 2003
Levalbuterol compared to racemic albuterol: efficacy and outcomes in patients hospitalized with COPD or asthmaTerrance Truitt, James Witko, Michael Halpern
Materials Management in Health Care|August 12, 2006
Trend shows growing orthopedic surgery case load. Will surgeons be able to keep up?Steven Kurtz, Edmund Lau, Michael Halpern, et al.
Head & Neck|April 3, 2009
Impact of treating facilities' volume on survival for early-stage laryngeal cancerAmy Y Chen, Alex Pavluck, Michael Halpern, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|December 7, 2011
Single-pill vs free-equivalent combination therapies for hypertension: a meta-analysis of health care costs and adherenceBeth Sherrill, Michael Halpern, Shahnaz Khan, et al.
Pageof 3